Nippon Shinyaku

Nippon Shinyaku Co., Ltd. is a pharmaceutical and health food manufacturer based in Kyoto, Japan, with operations extending internationally, including Switzerland. Founded in 1911, the company specializes in the development and sale of a wide range of pharmaceutical products targeting various medical conditions, including urological diseases, inflammation, allergies, hematologic malignancies, cardiovascular issues, and gastrointestinal disorders. Notable products include treatments for prostate cancer, erectile dysfunction, pulmonary arterial hypertension, and muscular dystrophy, among others. In addition to its pharmaceutical segment, Nippon Shinyaku produces functional food items, such as health food ingredients, preservatives, protein preparations, and spices. The company is also engaged in research and development activities that encompass pharmaceuticals and nutraceuticals, with a focus on genomic drug discovery and pharmacokinetics. Nippon Shinyaku aims to enhance its operational capabilities through potential mergers and acquisitions to support its growth in research, development, manufacturing, and marketing.